Humulin r 500 unit/ML kwikpen 3ML
Ended Awarded
- Contract number
- SPE2DB26FH6QK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,207
Award facts
- Contract value 100% obligated
- $20,206.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $20,206.97 for Humulin R 500 Unit/mL KwikPen 3mL insulin products on October 29, 2025, with completion targeted for October 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of DLA contract awards demonstrates its capability to meet federal procurement requirements through open competition, with previous deliveries including diabetes medications, neurological treatments, pain management pharmaceuticals, and other medical supplies. This delivery order for insulin products supports the Defense Health Agency and broader military healthcare operations, leveraging AmerisourceBergen's established capacity as a trusted pharmaceutical supplier to federal medical supply chains.
Quick answers
Who was awarded contract SPE2DB26FH6QK?
SPE2DB26FH6QK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FH6QK worth?
The government has obligated $20,207 on SPE2DB26FH6QK.
Is contract SPE2DB26FH6QK an order under another contract?
Yes. SPE2DB26FH6QK is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB26FH6QK competed?
The extent of competition for SPE2DB26FH6QK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award